These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20421387)

  • 1. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
    Gronbach K; Eberle U; Müller M; Olschläger TA; Dobrindt U; Leithäuser F; Niess JH; Döring G; Reimann J; Autenrieth IB; Frick JS
    Infect Immun; 2010 Jul; 78(7):3036-46. PubMed ID: 20421387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host gene expression in the colon of gnotobiotic interleukin-2-deficient mice colonized with commensal colitogenic or noncolitogenic bacterial strains: common patterns and bacteria strain specific signatures.
    Bohn E; Bechtold O; Zahir N; Frick JS; Reimann J; Jilge B; Autenrieth IB
    Inflamm Bowel Dis; 2006 Sep; 12(9):853-62. PubMed ID: 16954804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.
    Waidmann M; Bechtold O; Frick JS; Lehr HA; Schubert S; Dobrindt U; Loeffler J; Bohn E; Autenrieth IB
    Gastroenterology; 2003 Jul; 125(1):162-77. PubMed ID: 12851881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids.
    Pradhan S; Weiss AA
    mBio; 2020 Jul; 11(4):. PubMed ID: 32636253
    [No Abstract]   [Full Text] [Related]  

  • 5. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain.
    da Silva TF; Glória RA; de Sousa TJ; Americo MF; Freitas ADS; Viana MVC; de Jesus LCL; da Silva Prado LC; Daniel N; Ménard O; Cochet MF; Dupont D; Jardin J; Borges AD; Fernandes SOA; Cardoso VN; Brenig B; Ferreira E; Profeta R; Aburjaile FF; de Carvalho RDO; Langella P; Le Loir Y; Cherbuy C; Jan G; Azevedo V; Guédon É
    BMC Microbiol; 2023 Nov; 23(1):364. PubMed ID: 38008714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917.
    Nougayrède JP; Chagneau CV; Motta JP; Bossuet-Greif N; Belloy M; Taieb F; Gratadoux JJ; Thomas M; Langella P; Oswald E
    mSphere; 2021 Aug; 6(4):e0062421. PubMed ID: 34378987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.
    Ukena SN; Westendorf AM; Hansen W; Rohde M; Geffers R; Coldewey S; Suerbaum S; Buer J; Gunzer F
    BMC Med Genet; 2005 Dec; 6():43. PubMed ID: 16351713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.
    Westendorf AM; Gunzer F; Deppenmeier S; Tapadar D; Hunger JK; Schmidt MA; Buer J; Bruder D
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):373-84. PubMed ID: 15708311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
    Guzy C; Paclik D; Schirbel A; Sonnenborn U; Wiedenmann B; Sturm A
    Int Immunol; 2008 Jul; 20(7):829-40. PubMed ID: 18448456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.
    Bleich A; Sundberg JP; Smoczek A; von Wasielewski R; de Buhr MF; Janus LM; Julga G; Ukena SN; Hedrich HJ; Gunzer F
    Int J Exp Pathol; 2008 Feb; 89(1):45-54. PubMed ID: 18005134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.
    Kleta S; Steinrück H; Breves G; Duncker S; Laturnus C; Wieler LH; Schierack P
    J Appl Microbiol; 2006 Dec; 101(6):1357-66. PubMed ID: 17105567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation.
    Hancock V; Dahl M; Klemm P
    J Med Microbiol; 2010 Apr; 59(Pt 4):392-399. PubMed ID: 20110388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
    Sturm A; Rilling K; Baumgart DC; Gargas K; Abou-Ghazalé T; Raupach B; Eckert J; Schumann RR; Enders C; Sonnenborn U; Wiedenmann B; Dignass AU
    Infect Immun; 2005 Mar; 73(3):1452-65. PubMed ID: 15731043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.
    Adediran J; Leatham-Jensen MP; Mokszycki ME; Frimodt-Møller J; Krogfelt KA; Kazmierczak K; Kenney LJ; Conway T; Cohen PS
    Infect Immun; 2014 Feb; 82(2):670-82. PubMed ID: 24478082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917.
    Manzhalii E; Hornuss D; Stremmel W
    World J Gastroenterol; 2016 Jun; 22(23):5415-21. PubMed ID: 27340358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.
    Hancock V; Vejborg RM; Klemm P
    Mol Genet Genomics; 2010 Dec; 284(6):437-54. PubMed ID: 20886356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the non-commensal Methylococcus capsulatus Bath on mammalian immune cells.
    Christoffersen TE; Olsen Hult LT; Solberg H; Bakke A; Kuczkowska K; Huseby E; Jacobsen M; Lea T; Kleiveland CR
    Mol Immunol; 2015 Aug; 66(2):107-16. PubMed ID: 25771177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.